Effects of a Motilin Receptor Agonist (ABT-229) on Upper Gastrointestinal Symptoms in Type 1 Diabetes Mellitus: A Randomised, Double Blind, Placebo Controlled Trial
Gut - United Kingdom
doi 10.1136/gut.49.3.395
Full Text
Open PDFAbstract
Available in full text
Categories
Date
September 1, 2001
Authors
Publisher
BMJ